- Earnings season, banks show strength.
- Trump wants to set interest rates.
- Industrial production in the USA is rising.
- RAM manufacturers benefit from shortages.
- Earnings season, banks show strength.
- Trump wants to set interest rates.
- Industrial production in the USA is rising.
- RAM manufacturers benefit from shortages.
Investor sentiment at the end of the week improves the financial sector, which draws market attention with its results. Most companies in this industry positively surprise expectations, supporting the main indices. Investors are also already discounting the potential risk of conflict in Iran, as shown by oil prices. The leader of growth is NASDAQ100, whose contracts are rising by about 4%. S&P500 and Russell limit growth to around 0.2%. The Dow is performing the worst, with contracts falling by about 0.1%.
However, the good results of financial companies are weighed down by statements from Donald Trump. The market has not forgotten the dispute between Jerome Powell and the president's administration. At the same time, the president loudly expressed ideas about introducing an upper limit on loan interest rates for banks in the USA.
Macroeconomic data:
Today, investors received data from the US industry, which according to FED data was doing well in December 2025.
Industrial production increased by 0.4% month-on-month. The annual growth fell from 2.52% to 2%. The manufacturing industry surprised by growing 0.2% despite expectations of a monthly decline. Total capacity utilization increased to 76.3%.
US100 (D1)
Source: xStation5
The market is approaching a key moment where it will have to decide on passing through the resistance zone at 25900. If buyers fail to overcome the level for the fourth time, supply may take the initiative and bring the price around FIBO 38.2.
Company news:
- AST SpaceMobile (ASTS.US): The company is up over 7% after signing contracts for air defense systems.
- Micron (MU.US): The market values further growth of RAM manufacturers amid extreme shortages in this market. The company's valuations are rising by about 4%.
- BlackRock (BLK.US): The well-known fund significantly exceeds market expectations in results. EPS reaches $13.16, and revenues rise to $7 billion. The company rises at the opening by about 7%.
- ImmunityBio (IBRX.US): The biotech company is up 17% after preliminary net profit estimates turned out to be 700% higher than expectations.
- Regions Financial Corporation (RF.US): The company turned out to be an infamous exception in the bank earnings season. As one of the few financial institutions, it disappointed expectations both in terms of EPS and revenues. The stock price falls by over 3%.
Divorce of Europe and the USA over Greenland
⏬Oil and Silver Retreat on Trump
⏫Silver surges nearly 7%
Defense Companies in 2026 – Who stands to gain or lose?
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
